Oxazoloisoindolinones with in vitro antitumor activity selectively activate a p53-pathway through potential inhibition of the p53–MDM2 interaction.

Autor: Soares, Joana1,2, Pereira, Nuno A.L.3, Monteiro, Ângelo3, Leão, Mariana1,2, Bessa, Cláudia1,2, dos Santos, Daniel J.V.A.3,4, Raimundo, Liliana1,2, Queiroz, Glória1,5, Bisio, Alessandra6, Inga, Alberto6, Pereira, Clara1,2, Santos, Maria M.M.3 mariasantos@ff.ulisboa.pt, Saraiva, Lucília1,2 lucilia.saraiva@ff.up.pt
Zdroj: European Journal of Pharmaceutical Sciences. Jan2015, Vol. 66, p138-147. 10p.
Databáze: Academic Search Ultimate